Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_provenance.
- NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_provenance.
- NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_assertion evidence source_evidence_literature NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_provenance.
- NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_assertion SIO_000772 23633485 NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_provenance.
- NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_assertion wasDerivedFrom befree-2016 NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_provenance.
- NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_assertion wasGeneratedBy ECO_0000203 NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_provenance.
- befree-2016 importedOn "2016-02-19" NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_provenance.